Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 455, 883-884 (16 October 2008) | doi:10.1038/455883a; Published online 15 October 2008
Open Innovation Challenges
-
Methods of Modeling Adaptation in Populations
The analysis of adaptation with a population is a frequently encountered computational modeling scen...
-
Direct Molecular Detection of Proteins and Nucleic Acids
This Challenge is looking for novel approaches to protein and nucleic acid detection. This is an Id...
- More Challenges
- Powered by:
nature jobs
Organic Chemistry
- Praj Matrix - Praj Industries Ltd
- Pune, Maharashtra Pune-411021 India
Senior Scientist, Cellular & Molecular Pharmacology
- Cortex Search Inc.
- Vancouver, British Columbia
Cancer: A ringleader identified
Charis Eng1
Abstract
The childhood cancer neuroblastoma can either run in families or occur sporadically. Several studies find that the gene ALK is a chief offender in this disease, because its germline mutations mediate both forms.
Neuroblastoma is the most common childhood cancer diagnosed before the age of one, and accounts for some 15% of all cancer deaths in children. Some patients inherit a genetic predisposition to neuroblastoma due to mutations in the germ line (cells that can give rise to all other cells in an organism); in others, the cancer is sporadic, that is, it may be caused by both germline and somatic (found only in tumour cells) mutations.
- Charis Eng is at the Genomic Medicine Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.
Email: engc@ccf.org
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastomaNature Letters to Editor (16 Oct 2008)
Prevalence and functional consequence of PHOX2B mutations in neuroblastomaOncogene Original Article
Identification of ALK as a major familial neuroblastoma predisposition geneNature Article (16 Oct 2008)
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3BOncogene Original Article
See all 8 matches for Research